Şinasi Özsoylu & Sevgi Yetgin. (2007) About Megadose Methylprednisolone. Journal of Pediatric Hematology/Oncology 29:12, pages 864-865.
Crossref
Sevgi Yetgin & Şinasi Özsoylu. (2007) Comparison of Megadose Methylprednisolone Versus Conventional Dose Prednisolone in Hematologic Disorders. Journal of Pediatric Hematology/Oncology 29:4, pages 253-259.
Crossref
Gönül Hiçsönmez. (2006) The effect of steroid on myeloid leukemic cells: The potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Leukemia Research 30:1, pages 60-68.
Crossref
Gönül Hiçsönmez, Mualla Çetin, A.Murat Tuncer, İdil Yenicesu, Deniz Aslan, Emel Özyürek & Selma Ünal. (2004) Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment. Leukemia Research 28:1, pages 25-34.
Crossref
Bahattin Tunç, Ahmet F Öner & Gönül Hiçsönmez. (2003) The effect of short-course high-dose methylprednisolone on peripheral blood lymphocyte subsets in children with acute leukemia during remission induction treatment. Leukemia Research 27:1, pages 19-21.
Crossref
Safak Yuksel, Guray Saydam, Ruchan Uslu, Ulus Ali Sanli, Ender Terzioglu, Filiz Buyukececi & Serdar Bedii Omay. (2002) Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation. Leukemia Research 26:4, pages 391-398.
Crossref
Yoko Shimohakamada, Kenji Shinohara & Naofumi Fukuda. (2018) Remission of Acute Myeloblastic Leukemia After Severe Pneumonia Treated With High-Dose Methylprednisolone. International Journal of Hematology 74:2, pages 173-177.
Crossref
Øystein Bruserud, Bjørn Tore Gjertsen & Tien-sheng Huang. (2000) Induction of Differentiation and Apoptosis— A Possible Strategy in the Treatment of Adult Acute Myelogenous Leukemia. The Oncologist 5:6, pages 454-462.
Crossref
H.H. Aydin, N. Selvi, G. Saydam, M. Tobu, S. Uzunoglu, R. Uslu, F. Buyukkececi & S.B. Omay. (2000) Up-regulation of serine/threonine protein phosphatase type 2A regulatory subunits during methylprednisolone-induced differentiation of leukaemic HL-60 cells. Clinical & Laboratory Haematology 22:5, pages 271-274.
Crossref
Øystein Bruserud & Bjørn Tore Gjertsen. (2009) New Strategies for the Treatment of Acute Myelogenous Leukemia: Differentiation Induction—Present Use and Future Possibilities. STEM CELLS 18:3, pages 157-165.
Crossref
Selim Uzunoglu, Ruchan Uslu, Mahmut Tobu, Guray Saydam, Ender Terzioglu, Filiz Buyukkececi & Serdar Bedii Omay. (1999) Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. Leukemia Research 23:5, pages 507-512.
Crossref
Nam?k �zbek, Esra Erdemli, G�n�l Hi�s�nmez, Hamza Okur & Meral Tekelio?lu. (1999) Effects of methylprednisolone on human myeloid leukemic cells in vitro. American Journal of Hematology 60:4, pages 255-259.
Crossref
Allen F. Pyesmany, Lynne M. Ball, Margaret Yhap, M. Henry, Krista Laybolt, D. Christie Riddell & Dick van Velzen. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III
305
312
.
Lynne M. Ball, Allen F. Pyesmany, Margaret Yhap, Christopher L. Lannon, M. Henry, Krista Laybolt, D. Christie Riddell & Dick van Velzen. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III
297
303
.
Lynne M. Ball, Christopher L. Lannon, Margaret Yhap, Allen F. Pyesmany, M. Henry, Krista Laybolt, D. Christie Riddell & Dick van Velzen. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III
289
296
.
Allen F. Pyesmany, Lynne M. Ball, Margaret Yhap, M. Henry, Krista Laybolt, D. Christie Riddell & Dick van Velzen. 1999. Drug Resistance in Leukemia and Lymphoma III. Drug Resistance in Leukemia and Lymphoma III
281
287
.
G. HiçsÖnmez, F. Gümrük, P. V. Zamani, M. A. Tuncer, S. Yetgin, A. Gürgey, L. Atahan & S. Özsoylu. (2009) High‐dose methylprednisolone for children with acute lymphoblastic leukemia and unfavorable presenting features. European Journal of Haematology 58:1, pages 26-31.
Crossref